Start Date
February 28, 2026
Primary Completion Date
August 10, 2028
Study Completion Date
August 10, 2028
Midomafetamine
Initial dose of 80 or 120 mg midomafetamine HCl administered orally at the start of each of three psychotherapy sessions, followed by a supplemental half-dose of 40 to 60 mg midomafetamine HCl 1.5 to 2.5 hours later, unless contraindicated.
Non-directive therapy
Non-directive therapy will be conducted during Experimental Sessions.
Therapy
Therapy will be conducted during Preparatory Sessions and Integrative Sessions.
Lead Sponsor
Lykos Therapeutics
INDUSTRY